EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B

Yuhan Zeng, Danna Jiang, Lei Guo, Yizhang Chen, Jialu Weng, Xiaohan Liu, Sunting Qin, Mengyu Kong, Ziye Zhou iD, Xiuhua Zhang

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s553277 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Yuhan Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents, Cost-Benefit Analysis, Cost-Effectiveness Analysis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicAntiviral AgentsCost-Benefit AnalysisCost-Effectiveness AnalysisGuanineTenofovirHumansRetrospective StudiesFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

cost-effectiveness evaluationefficacyentecavirhepatitis Btenofovir amibufenamide

Substanzen

entecavirAntiviral AgentsGuanineTenofovir

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
  • Clinical Research Office, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Clinical Trial Institution Office, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

ORCID-Profile: Ziye Zhou

Zitieren

APA

Zeng, Y., Jiang, D., Guo, L., Chen, Y., Weng, J., Liu, X., Qin, S., Kong, M., Zhou, Z., & Zhang, X. (2026). Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s553277

Vancouver

Zeng Y, Jiang D, Guo L, Chen Y, Weng J, Liu X, et al. Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s553277

BibTeX
@article{Zeng2026,
  author = {Zeng, Yuhan and Jiang, Danna and Guo, Lei and Chen, Yizhang and Weng, Jialu and Liu, Xiaohan and Qin, Sunting and Kong, Mengyu and Zhou, Ziye and Zhang, Xiuhua},
  title = {Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s553277}
}
Kostenlos starten →